Pre-Annual General Meeting Information • Mar 20, 2024
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
Registered office: 9, rue de Bitbourg L-1273 Luxembourg R.C.S. Luxembourg: B255412
The holders of shares of BenevolentAI (the "Company")
are invited to attend the
of shareholders on 2 May 2024 at 14:00 CEST
at 2, place Winston Churchill, L-1340 Luxembourg (the "AGM").
At the AGM, the shareholders shall vote on the following agenda:
The AGM, after having reviewed the consolidated management report of the Board of Directors and the report of the independent auditor, approves the Consolidated Financial Statements for the financial year ended 31 December 2023 in their entirety, showing a consolidated loss for the financial year ended 31 December 2023 of GBP 63,317,000 established in accordance with the International Financial Reporting Standards as adopted by the European Union.
(3) Approval of the Company Annual Accounts for the financial year ended 31 December 2023.
The AGM, after having reviewed the management report of the Board of Directors and the report of the independent auditor, approves the Company Annual Accounts for the financial year ended 31 December 2023 in their entirety, showing a loss for the financial year ended 31 December 2023 of GBP 317,528,000 for the Company as parent company of the Group, established in accordance with the laws and regulation of the Grand Duchy of Luxembourg.
(4) Allocation of the results and remuneration of the members of the Board of Directors in relation to the financial year ended 31 December 2023.
The AGM acknowledges the loss for the financial year ended 31 December 2023 on a stand-alone basis of GBP 317,528,000 and that therefore no allocation to the Company's legal reserve is required.
The AGM, upon the proposal of the Board of Directors, decides to allocate the results of the Company based on the Company Annual Accounts for the financial year ended 31 December 2023 as follows:
| Loss for the financial year | GBP 317,528,000 |
|---|---|
| Loss brought forward (Report à nouveau) | GBP 701,011,000 |
| Results to be allocated and distributed | — |
| Allocation to the legal reserve | — |
| Loss carried forward | GBP 1,018,539,000 |
(4) Allocation of the results and remuneration of the members of the Board of Directors in relation to the financial year ended 31 December 2023 continued
The AGM sets the amount of total remuneration for the members of the Board of Directors in relation to the financial year ended 31 December 2023 at GBP 1,306,444, split as follows:
| Remuneration for the year ended 31 December 2023 | |||||||
|---|---|---|---|---|---|---|---|
| Total LTIP | |||||||
| Salary | Fees | Bonus | Benefits | awards | STFR | ||
| Name | GBP | GBP | GBP | GBP | GBP | GBP | |
| Non-Executive Director and Chair of the Board, and Acting CEO from 21 September 2023 |
|||||||
| Dr. François Nader | 227,404 | 99,825 | — | — | — | 327,229 | |
| Executive Director and CEO | |||||||
| Joanna Shields | |||||||
| (until 21 September 2023) | 395,544 | — | — | 21,151 | — | 416,695 | |
| Non-Executive Directors | |||||||
| Dr. John Orloff | — | 100,000 | — | — | — | 100,000 | |
| Jean Raby | — | 100,000 | — | — | — | 100,000 | |
| Dr. Jackie Hunter (until 21 June 2023) |
— | 37,949 | — | 4,315 | — | 42,264 | |
| Marcello Damiani (from 4 May 2023) |
— | 55,538 | — | — | — | 55,538 | |
| Prof Sir Nigel Shadbolt | — | 90,000 | — | — | — | 90,000 | |
| Dr. Olivier Brandicourt | — | 88,051 | — | — | — | 88,051 | |
| Dr. Susan Liautaud | — | 86,667 | — | — | — | 86,667 |
As required by the Luxembourg law of 24 May 2011 on the exercise of certain rights of shareholders in general meetings of listed companies, as amended (the "Luxembourg Shareholders' Rights Law"), the Company prepared a remuneration report for the financial year ended 31 December 2023 (the "Remuneration Report") and submits it to the advisory vote of the AGM. A copy of the Remuneration Report is available on the Company's website.
The AGM decides by an advisory vote to approve the Remuneration Report.
(5) Discharge of the members of the Board of Directors in relation to the financial year ended 31 December 2023.
The AGM decides to grant discharge to the members of the Board of Directors in relation to the financial year ended 31 December 2023.
(6) Renewal of the mandate of the Company's independent auditor in relation to the Company Annual Accounts and the Consolidated Financial Statements for the financial year ended 31 December 2024.
The AGM decides to renew the mandate of PricewaterhouseCoopers, société coopérative, with registered office at 2, rue Gerhard Mercator, L-2182 Luxembourg, Grand-Duchy of Luxembourg and registered with the Luxembourg trade and companies register (Registre de Commerce et des Sociétés, Luxembourg) under number B65477, as independent auditor to perform the independent audit of the Company Annual Accounts and the Consolidated Financial Statements regarding the financial year ended 31 December 2024.
(7) Acknowledgement of the resignation of Ms Joanna Shields as member of the Board of Directors, granting discharge to such resigning member and the appointment of Dr. Joerg Moeller for a term ending on the date of the annual general meeting of shareholders of the Company to be held in 2027. It is proposed that Dr. Joerg Moeller acts as an Executive Director.
The AGM resolves to acknowledge the resignation of Ms Joanna Shields as member of the Board of Directors with effect as of 21 September 2023, and further resolves to grant her full discharge for the exercise of her mandate for the period from 1 January 2023 to 21 September 2023.
The AGM further resolves to appoint Dr. Joerg Moeller, born in Bochum, Germany, on 10 November 1964, professionally residing at 4-8 Maple Street, London W1T 5HD, United Kingdom, as member of the Board of Directors, for a term ending on the date of the annual general meeting of shareholders of the Company to be held in 2027.
The AGM notes and acknowledges that it is proposed that Dr. Joerg Moeller acts as an Executive Director.
(8) Acknowledgement of the resignation of Dr. Jackie Hunter as member of the Board of Directors, granting discharge to such resigning member.
The AGM resolves to acknowledge the resignation of Dr. Jackie Hunter as member of the Board of Directors with effect as of 21 June 2023, and further resolves to grant her full discharge for the exercise of her mandate for the period from 1 January 2023 to 21 June 2023.
(9) Approval of the amended remuneration policy of the Company (the "Amended Remuneration Policy").
The AGM decides by an advisory vote to approve the Amended Remuneration Policy to reflect a general refresh of the policy and an update of the structure of remuneration of the Executive Director(s). A redline version of the Amended Remuneration Policy is available on the Company's website.
Pursuant to the articles of association of the Company (the "Articles of Association") and the law of 10 August 1915 on commercial companies, as amended from time to time, all the resolutions will be passed at a simple majority of the votes validly cast, without any quorum requirement.
Pursuant to the Luxembourg Shareholders' Rights Law, one or several shareholders holding together at least five percent (5%) of the Company's issued share capital may in writing (i) request to put one or several items onto the agenda of the AGM, provided that the request is accompanied by a justification or draft resolution(s) to be adopted by the AGM, or (ii) table draft resolutions for items included or to be included on the agenda of the AGM. Pursuant to article 4 of the Luxembourg Shareholders' Rights Law and article 13.18 of the Articles of Association, such request and justification or draft resolution(s) must be received at the Company's registered office by registered letter (to the attention of the Board of Directors, 9, rue de Bitbourg, L-1273 Luxembourg) or by e-mail (to: [email protected]) at least twenty-two (22) days prior to the date of the AGM, i.e. by 10 April 2024, accompanied by the address or e-mail address of the sender which the Company may use in order to deliver the acknowledgement of receipt of such request which it must do within forty-eight (48) hours of receipt. If such request entails a modification of the agenda of the AGM, the Company will make an amended agenda available at the latest fifteen (15) days prior to the date of the AGM, i.e. by 17 April 2024.
The documents related to the aforementioned items on the agenda will be on display for inspection by the shareholders on the Company's website (www.benevolent.com/investors) and at the registered office of the Company as from 20 March 2024. Upon request to ABN AMRO ([email protected]) or to the Company ([email protected]), copies of the above-mentioned documents will be e-mailed to the shareholders.
As of the date hereof, the Company's issued share capital is set at one hundred forty-five thousand one hundred twenty-six point three zero three euro (€145,126.303), represented by (i) one hundred forty-two million six hundred twenty-six thousand three hundred three (142,626,303) class A shares without nominal value and (ii) two million five hundred thousand (2,500,000) convertible class B shares without nominal value. Out of the total number of shares issued by the Company, twenty million six hundred eighty-six thousand four hundred nineteen (20,686,419) class A shares are currently held in treasury and do not, consequently, carry voting rights. The difference between the total number of shares, one hundred forty-five million one hundred twenty-six thousand three hundred three (145,126,303), and the treasury shares, twenty million six hundred eighty-six thousand four hundred nineteen (20,686,419), is one hundred twenty-four million four hundred thirty-nine thousand eight hundred eighty-four (124,439,884). Each one of these one hundred twenty-four million four hundred thirty-nine thousand eight hundred eighty-four (124,439,884) shares entitles its holder to one vote.
According to article 5 of the Luxembourg Shareholders' Rights Law and article 13.12 of Articles of Association, the record date for general shareholders' meetings of listed companies incorporated under the laws of the Grand Duchy of Luxembourg is set at fourteen (14) days prior to (and excluding) the date of the corresponding general shareholders' meeting. Therefore, any shareholder who holds one or more shares of the Company on 18 April 2024 at 24:00 (midnight) CEST (the "Record Date") shall be admitted to participate and vote at the AGM.
Shareholders wishing to attend the AGM in person must register (i) via www.abnamro.com/evoting or (ii) via the financial intermediary with whom the shareholder is registered as a shareholder of the Company as of 19 April 2024, but no later than 26 April 2024 at 17:00 CEST. In all circumstances, the financial intermediary must provide an electronic statement to ABN AMRO via www.abnamro.com/intermediary stating the shares were registered in the name of the shareholder thereof on the Record Date whereupon the shareholder will receive a proof of registration (the "Registration Certificate") which will serve as an admission ticket for the AGM. In addition, the financial intermediary is requested to include the full address details of the relevant shareholder in order to be able to verify the shareholding on the Record Date in an efficient manner.
Shareholders wishing to attend the AGM in person must bring their admission ticket and a proof of their identity (in the form of a non-expired identity card or passport) to the AGM. For the AGM to proceed in a timely and orderly manner, shareholders are requested to arrive in time. The doors will open at 13:30 CEST and the AGM will start promptly at 14:00 CEST.
Holders of shares who are unable to attend the AGM may exercise their voting rights electronically by giving a proxy with voting instructions (i) via www.abnamro.com/evoting or (ii) to the financial intermediary with whom the shareholder is registered as a shareholder of the Company no later than 26 April 2024 at 17:00 CEST.
Shareholders may also cast their votes by giving a proxy with voting instructions, together with a copy of a valid identity document and a certificate showing the number of shares recorded in their account as of the Record Date, to ABN AMRO via [email protected] no later than 26 April 2024 at 17:00 CEST. Such a proxy form is available on the Company's website www.benevolent.com/investors.
Forms that are not dated and signed or in which no vote is expressed, or which do not indicate an abstention or that are not received within the deadlines, will not be taken into account and shall be void.
Shareholders having submitted a proxy with voting instructions in due time but who wish to revoke such proxy may do so by timely providing a later-dated proxy with voting instructions or by timely cancelling such proxy in writing to ABN AMRO (i) via www.abnamro.com/evoting (if they have cast their votes via the voting platform in accordance with the first paragraph of this section "Proxies and Voting Instructions"), (ii) at [email protected] (if they cast their votes via that email address in accordance with the second paragraph of this section "Proxies and Voting Instructions") or (iii) to the financial intermediary with whom the shareholder is registered as a shareholder.
Only the last valid proxy with voting instructions received by ABN AMRO no later than 26 April 2024 at 17:00 CEST will be considered, unless that proxy with voting instructions has been validly cancelled prior thereto.
No later than 26 April 2024 at 19:00 CEST, the financial intermediaries must provide an electronic statement to ABN AMRO via www.abnamro.com/intermediary stating the number of class A shares held through Euroclear Nederland at the Record Date by each relevant shareholder and the number of such class A shares for which registration has been requested. ABN AMRO will send such shareholders a proof of registration via the relevant financial intermediary.
Shareholders who have the right to participate in the AGM (please see above sections "Right to Participate in the AGM" and "Proxies and Voting Instructions") shall have the right to ask questions to the Company concerning items on the agenda ahead of and during the AGM.
Shareholders wishing to submit questions ahead of the AGM must do so in writing, by submitting their questions, along with their full name, via e-mail to [email protected], no later than 24 April 2024. Without prejudice to the below, questions submitted after this deadline will not be answered and any questions submitted by other means will not be considered.
Shareholders attending the AGM shall also have the right, during such AGM, to ask questions related to the items of the agenda, subject to the provisions of the following paragraph and to measures the Company may take to ensure the identification of these shareholders.
Questions will be answered at the reasonable discretion of the Company and the Company is not required to answer all questions. In particular, questions may be summarised, combined or separated. Reasonable questions may be selected in the interest of the other shareholders, and questions from shareholders' associations and institutional investors with significant voting interests may be given preference. Where the relevant information is available on its website in a question and answer format, the Company shall be deemed to have answered the questions asked by referring to its website.
The AGM will be held in English language.
Luxembourg, 20 March 2024.
The Board of Directors

9, rue de Bitbourg L-1273 Luxembourg R.C.S. Luxembourg: B255412
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.